104 related articles for article (PubMed ID: 12450699)
1. Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals.
Sönmez E; Sönmez AS; Bayindir Y; Coskun D; Aritürk S
Vaccine; 2002 Dec; 21(3-4):243-6. PubMed ID: 12450699
[TBL] [Abstract][Full Text] [Related]
2. Effective antibody response in newborn babies living in Maldives to simultaneous vaccination against hepatitis B, poliomyelitis, diphtheria and tetanus.
Da Villa G; Picciotto L; Ribera G; Bencivenga M; Cotugno M; Hartmann P
Vaccine; 1995 Jun; 13(9):795-8. PubMed ID: 7483799
[TBL] [Abstract][Full Text] [Related]
3. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
Tregnaghi M; Zambrano B; Santos-Lima E
Pediatr Infect Dis J; 2012 Jan; 31(1):e24-30. PubMed ID: 22157567
[TBL] [Abstract][Full Text] [Related]
4. Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid.
Riner DK; Ndombi EM; Carter JM; Omondi A; Kittur N; Kavere E; Korir HK; Flaherty B; Karanja D; Colley DG
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005180. PubMed ID: 27926921
[TBL] [Abstract][Full Text] [Related]
5. A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix(®) in subjects aged 11-17 years: an open, randomised, controlled trial.
Østergaard L; Silfverdal SA; Berglund J; Flodmark CE; West C; Bianco V; Baine Y; Miller JM
Vaccine; 2012 Jan; 30(4):774-83. PubMed ID: 22107850
[TBL] [Abstract][Full Text] [Related]
6. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
[TBL] [Abstract][Full Text] [Related]
7. Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2,3,4 months schedule with a fourth dose at 12-18 months of age.
Habermehl P; Leroux-Roels G; Sänger R; Mächler G; Boutriau D
Hum Vaccin; 2010 Aug; 6(8):640-51. PubMed ID: 20697200
[TBL] [Abstract][Full Text] [Related]
8. Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants.
Madhi SA; Koen A; Cutland C; Groome M; Santos-Lima E
Pediatr Infect Dis J; 2013 Aug; 32(8):889-97. PubMed ID: 23538523
[TBL] [Abstract][Full Text] [Related]
9. Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy.
Giammanco G; Li Volti S; Mauro L; Bilancia GG; Salemi I; Barone P; Musumeci S
Vaccine; 1991 Oct; 9(10):747-50. PubMed ID: 1836919
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines.
Wheeler CM; Bautista OM; Tomassini JE; Nelson M; Sattler CA; Barr E;
Vaccine; 2008 Jan; 26(5):686-96. PubMed ID: 18164106
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.
Knöll A; Hottenträger B; Kainz J; Bretschneider B; Jilg W
Vaccine; 2000 Apr; 18(19):2029-32. PubMed ID: 10706965
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
[TBL] [Abstract][Full Text] [Related]
13. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.
Vesikari T; Forstén A; Desole MG; Ferrera G; Caubet M; Mesaros N; Boutriau D
Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785
[TBL] [Abstract][Full Text] [Related]
14. The effect of concurrent use of hepatitis B and Bacille Calmette-Guérin vaccination on anti-hepatitis B response.
Artan R; Erol M; Velipasaoglu S; Yegin O
Saudi Med J; 2004 Dec; 25(12):1939-42. PubMed ID: 15711671
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous administration of HB recombinant vaccine with diphtheria and tetanus toxoid and oral polio vaccine: a pilot study.
Barone P; Mauro L; Leonardi S; Ienna M; Giammanco Bilancia G; Falcidia E; Musumeci S
Acta Paediatr Jpn; 1991 Aug; 33(4):455-8. PubMed ID: 1838852
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic.
Prymula R; Kieninger D; Feroldi E; Jordanov E; B'Chir S; DaCosta X
Pediatr Infect Dis J; 2018 Aug; 37(8):823-830. PubMed ID: 29762363
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adults.
Aguilar-Betancourt A; González-Delgado CA; Cinza-Estévez Z; Martínez-Cabrera J; Véliz-Ríos G; Alemán-Zaldívar R; Alonso-Martínez MI; Lago-Baños M; Puble-Alvarez N; Delahanty-Fernandez A; Juvier-Madrazo AI; Ortega-León D; Olivera-Ruano L; Correa-Fernández A; Abreu-Reyes D; Soto-Mestre E; Pérez-Pérez MV; Figueroa-Baile N; Pérez LH; Rodríguez-Silva A; Martínez-Díaz E; Guillén-Nieto GE; Muzio-González VL
Hum Vaccin; 2008; 4(1):54-9. PubMed ID: 18441530
[TBL] [Abstract][Full Text] [Related]
18. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
[TBL] [Abstract][Full Text] [Related]
19. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
[TBL] [Abstract][Full Text] [Related]
20. Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid.
Bernstein HH; Seyferth ER
Vaccine; 2017 Dec; 35(48 Pt B):6707-6711. PubMed ID: 29054729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
